Global Journal of Cancer Therapy Submit Manuscript

    Introduction

    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesNo
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Articles digitally archived in PORTICO
    • Permanent article identifierDOI (Digital Object Identifier) We provide DOI to all published papers to facilitate higher citation and classification of articles.
      Peertechz Publisher ID: 10.17352
    • Type of LicenseCreative Commons
      • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
    • Show +

    Editor-in-Chief

    M.Waheed Roomi

    M.Waheed Roomi
    Dr. Rath Research Institute
    1260 Memorex Drive, Santa Clara, USA
    Email: [email protected]
    Tel: (408)730-4481
    Fax: (408) 588-7174

    More Info.

    Tsuyoshi Shirakawa

    Tsuyoshi Shirakawa
    Kyushu University, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
    Email: [email protected]
    Tel: +81-92-661-5395
    Fax: +81-955-70-1511

    More Info.


    Welcome from the desk of

    Dr. Tsuyoshi Shirakawa, MD., Executive Editor

    Welcome to our website! I am very happy for your visit.

    Global Journal of Cancer Therapy reports both clinical and experimental results related to cancer, and is using online review and Editorial Manager System for quality review process. The Journal invites all type of clinical and medical case reports, case studies, basic researches, clinical images, pharmacology and nursing, as it were, total oncology. The goal of us is to keep a record of the state-of-the-art research or case report and to promote study, research and improvement within its various specialties, then to develop total oncology.

    We believe your expertise knowledge will help in the growth of the journal and as well help many budding research scientists all around the world. Your article will be a key insight into real medical cases that are essential for physicians, and may ultimately help to improve patient outcomes.

    Editorial Board

    Muzafar Ahmad Macha
    Department of Biochemistry
    Molecular Biology University Nebraska Medical Center
    USA
    GJCT

    Research Interest : Animal handling: Oral cavity/pancreatic cancer orthotopic and subcutaneous xenograft models; Protein technology: Protein estimation, SDS PAGE, western blotting, 2D gel electrophoresis, Immunoprecipitation; Recombinant DNA technology: bacterial culture and preparation of competent cells; Cell culture technique: isolation of genomic plasmid/DNA/RNA isolation, PCR, RT-PCR, Real time PCR, Electrophoretic mobility shift assay (EMSA), chromatin immunoprecipitation (CHIP), cell proliferation and viability assays, invasion and motility assay, scratch assay, immunocytochemistry, confocal laser scan microscopy, FACS analysis, ELISA, immunohistochemistry


    More Info.
    Maria Saridi
    Director Nursing
    University of Peloponnese
    Greece
    GJCT
    Research Interest: Nursing Care Delivery Systems, Community Nursing, Hospital Information Systems, Surgical Nursing, Health Education, Prevention, Nosocomial Infections, Occupational Health, Community Healthcare
    More Info.
    George F Samelis
    Medical Oncologist
    President of the Hellenic and International Society of Molecular
    National and Kapodistrian University of Athens
    Greece
    GJCT

    Research Interest: Lung-Pancreatic-Prostate-Cancers, Molecular Targeted Therapies


    More Info.
    Rosaria Benedetti
    Second University of Naples Italy
    Italy
    GJCT

    Rsearch Interest: Molecular Biology, Cell Biology, Cancer Research

    More Info.
    Ana Livia Silva Galbiatti
    Faculdade de Medicina de São José do Rio Preto
    Brazil
    GJCT

    Research Interest: Head And Neck Cancer, Genetics, Molecular Biology, Cell Line, Chemoterapeutics, Genetic Polymorphisms


    More Info.
    Dhruv Kumar
    Pharmacology, Toxicologyand Theraputics
    The University of Kansas Medical Center,
    USA
    GJCT

    Research Interest: Biological Skills. Plasmid Amplification And Purification, Transformation, Transfection, Transduction,Protein Isolation, Western Blot, Cell Viability And Apoptosis Assay, FluorescenceMicroscopy, Flow Cytometry, Real-Time PCR, Tissue Processing, Tissue Culture,Immunohistochemistry, XF Flux Analyzer And Mice Handling.Biophysical Skills. A Complete Understanding Of Atomic Force Microscopy To Study IntrinsicallyUnstructured Proteins Related To Neurodegenerative Disease (Parkinson’s AndAlzheimer’s Disease).Bioinformatics Skills. Software: Python, Autodock, NCBI Software Suits, Rasmol, Clustal-X And W, VMD,Phylip, Tree View,Pymol, Arguslab And Genscan Etc. Biological Databases: Genbank, EMBL, DDBJ, Pfam, PDB, Swiss Prot, Trembl Etc. Muser Friendly With Proteomics Server Expasy.Information Technology Skills


    More Info.
    Wang Fan
    Attending Physician
    The First Peoples Hospital of Jingmen
    China
    GJCT

    Research Interest: Glioma, Circadian Gene, Radiotherapeutic Sensitivity, Carcinogenesis

    More Info.
    Tomasz Skora
    Gastrointestinal and Genitourinary Cancer
    Maria Sklodowska-Curie Memorial Institute
    Poland
    GJCT

    Research Interest: Radiotherapy, Proton Therapy, Particle Therapy, Gastrointestinal Cancers, Genitourinary Cancers, Anal Canal Cancer, Rectal Cancer, Gastric Cancer, Seminoma, Bladder Cancer, Prostate Cancer


    More Info.
    Qinong Ye
    Professor
    Department of Medical Molecular Biology/Oncology
    Beijing Institute of Biotechnology
    China
    GJCT

    Research Interest: Molecular Basis Of Cancer; Cell Signaling; Epigenetics; DNA Damage Response


    More Info.
    Kailash Chadha
    Department of Molecular and Cellular Biology
    Roswell Park Cancer Institute
    USA
    GJCT

    Research Interest: The Physiological Role Of PSA In Prostate Tissue Microenvironment, In Prostate Tumor Growth And Progression, And In Prostate Cancer Metastasis Is Not Known. Attenuation Of PSA Levels With Age, Disease Progression, Or During Androgen Deprivation Therapy, However, Removes This Important Regulator Of Angiogenesis, And By Extension Results In Tumor Progression. Re-Introduction Of Human PSA Into The Prostate Tissue Microenvironment May Suppress Tumor Angiogenesis Through Either The Inhibition Of Expression Of Pro-Angiogenic Genes Or Induction Of Expression Of Anti-Angiogenic Genes, Or Via Inhibition Of Signaling Mechanisms Associated With Angiogenesis That Are Independent Of Gene Transcription. Validation Of An Anti-Angiogenic Effect Of PSA On The Human Tissue Vasculature In A Pre-Clinical Model Of Primary Xenografts Of Human Prostate And Prostate Cancer Tissue Will Provide Compelling Evidence That PSA Has Therapeutic Potential Against Prostate Cancer.



    More Info.
    Karim Essani
    Professor
    Department of Biological Sciences
    Western Michigan University
    USA
    GJCT
    Research Interest: Virus, Poxvirus, Tanapoxvirus, Virotherapy, Oncolytic viruses
    More Info.
    Shinq-Jen Wu
    Da-Yeh University
    Taiwan
    GJCT

    Research Interest: Shinq-Jen Wu, Da-Yeh University, Chang-Hwa, Taiwan


    More Info.
    Wei Du
    Hematology and Cancer Biology
    Cincinnati Childrens Hospital Medical Center
    USA
    GJCT

    Research Interest: Stem Cell Biology And Pathophysiology Of Bone Marrow Failure And Leukemia; Identifying And Targeting The Alternative Oxidative DNA-Damage Response Pathways Required For Cancer Progression; The Role Of A Major Proliferating Protein, Nucleophosmin (NPM) In Cancer Development


    More Info.
    Edgar Selzer
    Professor
    Landesklinikum Wiener Neustadt
    Medical University Vienna
    Austria
    GJCT

    Research Interest:Oncology, Radiotherapy, Radiobiology, Head And Neck Cancer; Anti-Cancer Drug Research


    More Info.
    Vessela Vassileva
    Research Associate
    Department of Surgery & Cancer
    UCL Cancer Institute
    UK
    GJCT

    Research Interest: Research Interests And Career Have Focused On The Pathobiology And Treatment Of Cancer – From Identifying Key Genes And Molecular Pathways Involved In The Initiation, Development And Progression Of Cancer To Identifying Novel Treatments, Causes Of Resistance To Therapy In Solid Tumours And Strategies To Overcome Treatment Failure. She Has Wide Expertise In Oncology And Innovative Drug Development Gained From Her Academic, Publishing And Regulatory Experience.


    More Info.
    View more
    mendeley

    The Impact of Positive Thinking on Disease Progression in Oncology Patients

    DOI Logo 10.17352/2581-5407.000055

    Published On: January 13, 2026 | Pages: 001 - 003

    Author(s): Ivan Milosevic*
    Abstract View Full Article View
    mendeley

    Analysis and Control of Oncolytic Virotherapy Dynamic Models

    DOI Logo 10.17352/2581-5407.000054

    Published On: August 14, 2025 | Pages: 001 - 009

    Author(s): Lakshmi N Sridhar*
    Abstract View Full Article View
    mendeley

    ANXA2 Enhances the Malignancy of Gastric Cancer Cells by Remodeling Cytoskeleton

    DOI Logo 10.17352/2581-5407.000053

    Published On: October 23, 2024 | Pages: 001 - 008

    Author(s): Yujuan Zhou, Wanlin Che, Xue Bai, Danying Zhang, Wenxuan Zhang, Hongming Fang, Guochao Nie* and Yingchun Hou*
    Abstract View Full Article View
    mendeley

    Understand the chronic pain!

    DOI Logo 10.17352/2581-5407.000052

    Published On: May 08, 2024 | Pages: 001 - 002

    Author(s): Essam Abdelrazek*
    Abstract View Full Article View
    mendeley

    Melanoma and basal cell carcinoma: Mimickers of each other

    DOI Logo 10.17352/2581-5407.000051

    Published On: September 23, 2023 | Pages: 020 - 022

    Author(s): Gustavo de Sá Menezes Carvalho*, Isabella N Dana, Juliana Casagrande Tavoloni Braga and Ashfaq A Marghoob

    ORCID Logo  0000-0002-4556-1763

    Abstract View Full Article View
    mendeley

    Flawed foundation is the root cause of failure of medicine and precludes cures for chronic diseases

    DOI Logo 10.17352/2581-5407.000050

    Published On: September 15, 2023 | Pages: 001 - 019

    Author(s): Jianqing Wu* and Ping Zha
    Abstract View Full Article View
    mendeley

    New modalities of surgery for renal tumors in children: A Mini-Review

    DOI Logo 10.17352/2581-5407.000049

    Published On: November 29, 2022 | Pages: 051 - 052

    Author(s): Jan Godzinski*
    Abstract View Full Article View    
    mendeley

    Investigation of the effectiveness of ECOLAB ’Drape ArmourTM’ Radiation Protection in limiting eye-lens doses of healthcare personnel exposed to ionizing radiation during gastroenterology - interventional radiology procedures

    DOI Logo 10.17352/2581-5407.000048

    Published On: October 20, 2022 | Pages: 046 - 050

    Author(s): Fulvio IM Fucilli*, Giuseppe Di Giovanni, Alessandro Mastrorocco, Matteo Ninni, Piero Loprete, Isa De Crudis, Massimiliano Marano, Antonio Santomauro and Fabio Fucilli

    ORCID Logo  0000-0002-1132-0363

    Abstract View Full Article View
    mendeley

    The effects of thymoquinone and cytozine arabinoside on apoptosis and cell proliferation in acute myeloide leukemia

    DOI Logo 10.17352/2581-5407.000047

    Published On: October 11, 2022 | Pages: 040 - 045

    Author(s): Aslı Altun, Nurten Kara, Şengül Tural*, Alişan Yıldıran and Leman Tomak

    ORCID Logo  0000-0002-8946-8165

    Abstract View Full Article View    
    mendeley

    A first comprehensive look at the order-disorder nature of RTK KIT native and carcinogenic targets

    DOI Logo 10.17352/2581-5407.000046

    Published On: October 07, 2022 | Pages: 036 - 039

    Author(s): Luba Tchertanov* and Julie Ledoux

    ORCID Logo  0000-0001-6600-5494

    Abstract View Full Article View    

     

    Indexing/Archiving